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APPENDIX
Tissue preparation for immunostaining
Sections were deparaffinized in xylene-ethanol solution
and incubated in 2N hydrochloride (HCl) (for 5-bromode-
oxyuridine [BrdU] stain) for 30 minutes. After washing
with normal saline solution, sections were incubated with
1% hydrogen peroxide (H2O2) in methanol for 30 minutes.
After washing with phosphate-buffered saline solution
(PBS), sections were incubated with goat serum (1:200
diluted in PBS) for 20 minutes. Sections were then incu-
bated either with mouse anti-BrdU monoclonal antibody
(Becton Dickinson Immunocytometry Systems; 1:50 dilu-
tion in 1% bovine serum albumin [BSA] in PBS) or with
anti–a–smooth muscle (a-SM) actin mouse anti-human
monoclonal antibody (Sigma, St Louis, Mo; 1:400 dilution
in 1% BSA in PBS) or anti-mouse CD31 antibodies (Santa
Cruz Biotechnology; at a concentration of 20 mg/mL),
respectively. After PBS rinse, sections were incubated with
biotinylated anti-mouse immunoglobulin G antibody for
30 minutes with the avidin-biotin complex (ABC) method
(Vector Laboratories,) according to the manufacturer’s
protocol. Sections were counterstained with hematoxylin
before counting.
Preparation for dioxyuridine triphosphate nick end–
labeled (TUNEL) staining
Sections were deparaffinized, rehydrated, and incu-
bated in 1% H2O2 in methanol for 30 minutes. After PBS
washing, DNA fragmentation was detected with an in situ
apoptosis detection kit (Apop@Tag Plus Preoxidase; Inter-
gen), according to the manufacturer’s protocol. The sec-
tions were incubated with biotinylated secondary antibody
as required according to the manufacturer’s protocol (ABC
method). Sections were counterstained with hematoxylin.
Reverse transcriptase polymerase chain reaction
Complementary DNA synthesis. Contaminated
DNA was removed by treatment with deoxyribonuclease I
(Invitrogen). One microgram of total RNA was reverse
transcribed with Superscript II reverse transcriptase (In-
vitrogen) to cDNA.
Primers. Rat vascular endothelial growth factor
(VEGF), KDR, and platelet-derived growth factor-b
(PDGF-b) primers were designed from the rat cDNA of
VEGF-D (NM031836; forward primer 59-caagtcgcacactct-
gagga-39 and reverse primer 59-ggcgacttctacgcatgtct-39)
and PDGF-b (L40991; forward primer 59-cagcagagcctgc-
cgtaatc-39 and reverse primer 59-cgatgaggttccgcgagat-39).
These primers had been tested in rats to be enable amplifi-
cation of specific polymerase chain reaction (PCR) prod-
ucts. b-Actin primers were also designed from rat cDNA of
b-actin (L40991; forward primer 59-tcctggcctcactgtccac-39
and reverse primer 59-gggccggactcatcgtact-39) and tested
in rat to obtain specific PCR products.
Standard curve. The PCR products amplified by the
primers were purified and quantified. One nanogram of
each PCR product was stepwise diluted to serial picogram
concentrations. Reverse transcriptase (RT) PCR was per-
formed with the protocol below. RT-PCR results from
each primer pair were analyzed, and standard curves were
created.
Polymerase chain reaction. RT-PCR was performed
witih the GeneAmp 7700 Sequence Detection System (Ap-
plied Biosystems) according to the manufacturer’s instruc-
tions. Reactions were performed in a 20 mL volume with
0.8 mmol/L primers and 1 mg cDNA and SYBR Green
PCR Master Mix (Applied Biosystems). A typical protocol
included 2-minute incubation at 50° C for optimal AmpEr-
ase UNG enzyme activity, followed by 10 minutes at 95° C
for activation of AmpliTag Gold DNA polymerase, fol-
lowed by 40 cycles of 15-second denaturation at 95° C and
1-minute annealing and extension at different annealing
temperatures determined by each pair of primers. For con-
firmation of amplification specificity, RT-PCR products
were loaded on 2% agarose gel in 0.5 X TBE buffer for gel
electrophoresis. The RT-PCR products from each primer
pair were subjected to standard curve analysis and normal-
ized against b-actin expression.
Gelatin gel zymography
Samples were ground in liquid nitrogen, homogenized
in buffer (50 mmol/L Tris-HCl, 10 mmol/L calcium
dichloride [CaCl2], 2M guanidine HCl, 2.5% Triton
X-100), incubated on ice, and centrifuged at 4° C for 15
minutes. Supernatant was dialyzed against 50 mmol/L
Tris-HCl and 2.5% Triton X-100 overnight at 4° C. Sam-
ples were normalized for total protein content. For detec-
tion of MMP-2 and MMP-9 (gelatinase A and B, respec-
tively), equal amounts of tissue extract protein (20 mg),
assayed with the BCA protein assay (Bio-Rad), were loaded
on each lane and run in parallel in 10% sodium dodecylsul-
fate (SDS) polyacrylamide gel electrophoresis gels contain-
ing 1% gelatin. Gels were washed with Triton X-100 (2.5%)
to remove SDS, then incubated overnight (37° C) in de-
veloping buffer (50 mmol/L Tris base and 10 mmol/L
CaCl2). Zones of lysis were visualized after staining the gels
with 0.5% Coomassie blue R-250. Densitometric analysis
of lytic bands for MMP-2 and MMP-9 was performed by
public domain software NIH Image version 1.61.
